Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses.
Cancer Cell
; 34(3): 411-426.e19, 2018 09 10.
Article
in En
| MEDLINE
| ID: mdl-30146332
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rhabdomyosarcoma
/
Protein-Tyrosine Kinases
/
Nuclear Proteins
/
Biomarkers, Tumor
/
Cell Cycle Proteins
/
Muscle Neoplasms
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
Language:
En
Journal:
Cancer Cell
Journal subject:
NEOPLASIAS
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United States